TG Therapeutics, Inc.

TGTX·NasdaqCM·Healthcare
Compare
61.63+0.88 (+1.45%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close60.75
Open61.85
Day range60.3162.78
52-week range26.7663.60
Off day high−1.83%
Off 52-week high−3.10%
Volume1.88M
Avg. volume (3M)1.80M
Market cap9.43B
EPS (TTM)2.75
Forward P/E22.76
P/E ratio (TTM)22.41
Dividend yield—
Beta (5Y)1.81
Shares outstanding153.08M
Short interest27.94% of float
Earnings dateNov 9, 2026
Analyst target69.71
Profit margin55.22%

Against its peers

Compare in full ›
TGTX ROIV B9A.F VERA 9969.HK GMAB
Market cap 9.43B 27.61B 2.45B 2.30B 21.56B 33.89B
P/E (TTM) 22.4 — 250.7 — 20.3 43.4
Forward P/E 22.8 -27.5 — -7.5 53.2 34.9
Price/book 14.5 6.5 1.2 5.6 1.9 5.5
Dividend yield — — 0.68% — — —
1-year change +78.47% +85.85% +13.08% +27.43% −14.61% +91.12%
Today +1.45% +6.08% −0.29% +4.10% +1.33% −0.72%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All TGTX news ›
markets.businessinsider.com·Positive

Tiziana Life Sciences (TLSA) Gets a Buy from BTIG

In a report released today, Thomas Shrader from BTIG maintained a Buy rating on Tiziana Life Sciences, with a price target of $7.00. According to TipRanks, Shrader is a 4-star analyst with an average return of 8.1% and a 40.12% success…

Defense World·Positive

TG Therapeutics (TGTX) Expected to Post Earnings on Monday

Check Out Our Latest Stock Analysis on TG Therapeutics TG Therapeutics, Inc is a commercial-stage biopharmaceutical company focused on developing and delivering medicines for B-cell diseases, including multiple sclerosis and certain blood…

From the 4Search news index, newest first.

In the news

23mentions in 30 days
6with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance